#Oncotarget

@lonnibesancon.bsky.social

8 months ago

Some potential image duplications found in this paper (http://www.ncbi.nlm

My Pubpeer concerns: pubpeer.com/publicat...

#imageduplication
#oncotarget

5 0 0 0

Lonni Besançon

@lonnibesancon.bsky.social

8 months ago

Jazf1 promotes prostate cancer progression by activating JNK/Slug | Oncotarget https://doi.org/10.18632/oncotarget.23146 Yonghun Sung, Song Park, Si Jun Park, Jain Jeong, Minjee Choi, Jinhee Lee, Wookbong Kwon, Soyoung Jang, Mee-Hyun Lee, Dong Joon Kim, Kangdong Liu, Sung-Hyun...

Some potential image duplications found in this paper (http://dx.doi.org/10

My Pubpeer concerns: pubpeer.com/publicat...

#imageduplication
#oncotarget

4 1 0 0

Lonni Besançon

@lonnibesancon.bsky.social

8 months ago

The dual PI3K/mTOR inhibitor dactolisib elicits anti-tumor activity in vitro and in vivo | Oncotarget https://doi.org/10.18632/oncotarget.23091 Fei Shi, Jinying Zhang, Hongyu Liu, Liangliang Wu, Hongyu Jiang, Qiyan Wu, Tianyi Liu, Meiqing Lou, Hao Wu

Some potential image duplications found in this paper (www.oncotarget.com/l...)

My Pubpeer concerns: pubpeer.com/publicat...

#imageduplication
#oncotarget

3 0 0 0

Lonni Besançon

@lonnibesancon.bsky.social

8 months ago

HBXIP activates the PPARδ/NF-κB feedback loop resulting in cell proliferation | Oncotarget https://doi.org/10.18632/oncotarget.23057 Qian Liu, Wenbin Lu, Chunxia Yang, Yue Wang, Wenjing Li, Ying Chu, Jianzhong Deng, Yongzhong Hou, Jianhua Jin

Some splicing and a potential image duplication found in this paper (doi.org/10.18632/onc...)

My Pubpeer concerns: pubpeer.com/publicat...

#imageduplication
#oncotarget

1 0 0 0

Retraction Watch

@retractionwatch.com.web.brid.gy

9 months ago

Apparent NCI director candidate wants ‘open, respectful’ post-publication peer review while promoting anonymous site that calls sleuths a ‘mob’ Brown University physician-scientist Wafik El-Deiry has been a longtime critic of the post-publication forum PubPeer, where 75 of his papers have been flagged. For example, in an April post on X, formerly Twitter, he stated, “It is not good that PubPeer has been weaponized and has become tyrannical.” In July 2024, he referred to the … Continue reading Apparent NCI director candidate wants ‘open, respectful’ post-publication peer review while promoting anonymous site that calls sleuths a ‘mob’

0 0 0 0

Retraction Watch

@retractionwatch.com.web.brid.gy

9 months ago

Apparent NCI director candidate wants ‘open, respectful’ post-publication peer review while promoting anonymous site that calls sleuths a ‘mob’ Brown University physician-scientist Wafik El-Deiry has been a longtime critic of the post-publication forum PubPeer, where 75 of his papers have been flagged. For example, in an April post on X, formerly Twitter, he stated, “It is not good that PubPeer has been weaponized and has become tyrannical.” In July 2024, he referred to the … Continue reading Apparent NCI director candidate wants ‘open, respectful’ post-publication peer review while promoting anonymous site that calls sleuths a ‘mob’

0 0 0 0

David Sanders

@davidsanderssci.bsky.social

1 year ago

It took me more than 2 years to get an article from the top university for retractions (Jilin) on #ovariancancer in males(!) in the terrible journal #Oncotarget retracted. Facilitation of fraud by journals & their editors & publishers is the main problem. #Research #integrity

4 0 2 0

Hao Yin

@haoyin.bsky.social

1 year ago

#MachineLearning ➡️ "ETS1 (enriched in #EndothelialCell T/B/NK cells) & ITPR3 as potential diagnostic genes for" #AbdominalAorticAneurysm

Trained
1⃣ GSE57691 #Oncotarget 2015
2⃣ CellAge
Validated
1⃣ #JAHA 2017 GSE98278
2⃣ #CSBJ 2023 GSE183464

#JCMM 2025
onlinelibrary.wiley.com/doi/10.1111/...

6 0 0 0

Morty

@mortenoxe.bsky.social

1 year ago

When will this #Oncotarget paper be retracted?

pubpeer.com/publications...

doi.org/10.18632/onc...

I reported it in 2018. After a correction, it has turned into a train wreck of manipulations.

1 0 0 0

Anviron

@anviron.bsky.social

1 year ago

#Oncotarget reported (Han 2015) breast tumors were reduced by #trastuzumab when combined w/ DPAGT1 inhibitors, even in #Her2 negative cancers. @anviron.bsky.social confirmed this paradox, DPAGT1 inhibitor, ANV221, upregulated Her2 in #TNBC, opening door to potent, targeted TNBC therapeutics.

1 1 0 0

Posts tagged #Oncotarget